"2023 ISTH update of the 2022 ISTH guidelines for antithrombotic treatment in COVID-19": comment from Flumignan et al.

被引：1
|
作者：
Flumignan, Ronald Luiz Gomes [1 ,2 ]
Nakano, Luis Carlos Uta [1 ,2 ]
de Amorim, Jorge Eduardo [1 ]
Atallah, Alvaro Nagib [1 ,2 ]
机构：
[1] Univ Fed Sao Paulo, Dept Surg, Div Vasc & Endovasc Surg, 754 Rua Borges Lagoa, BR-04038002 Sao Paulo, Brazil
[2] Univ Fed Sao Paulo, Cochrane Brazil, Sao Paulo, Brazil
来源：
JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2024年 / 22卷 / 09期
关键词：
D O I：
10.1016/j.jtha.2024.05.029
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2670 / 2671
页数：2
相关论文
共 50 条
  • [41] Benefits, Burden, and COVID-19: A Response to Dutheil et al. (2020)
    Eric Rubenstein
    Amy Kalkbrenner
    Heather Volk
    Laura McGuinn
    Journal of Autism and Developmental Disorders, 2021, 51 : 1808 - 1809
  • [42] Benefits, Burden, and COVID-19: A Response to Dutheil et al. (2020)
    Rubenstein, Eric
    Kalkbrenner, Amy
    Volk, Heather
    McGuinn, Laura
    JOURNAL OF AUTISM AND DEVELOPMENTAL DISORDERS, 2021, 51 (05) : 1808 - 1809
  • [43] Reply to "Predominance of visuoconstructive impairment after mild COVID-19?" by Diez-Cirarda et al. 2022
    de Paula, Jonas J.
    Duran, Fabio L. S.
    Busatto, Geraldo
    Miranda, Debora M.
    Romano-Silva, Marco A.
    MOLECULAR PSYCHIATRY, 2023, 28 (02) : 538 - 540
  • [44] Comment on Liu et al. Application of High-Flow Nasal Cannula in COVID-19: A Narrative Review. Life 2022, 12, 1419
    Crimi, Claudia
    Cortegiani, Andrea
    LIFE-BASEL, 2022, 12 (10):
  • [45] Comment on case series of COVID-19 in patients with myasthenia gravis: a single institution experience by Zupanic et al.
    Galassi, Giuliana
    Marchioni, Alessandro
    ACTA NEUROLOGICA BELGICA, 2022, 122 (02) : 559 - 560
  • [46] Comment on Cheng et al.'s "Risk factors for poor COVID-19 outcomes in patients with psychiatric disorders"
    Chu, Wei -Min
    Ho, Hsin-En
    Wei, James Cheng-Chung
    BRAIN BEHAVIOR AND IMMUNITY, 2024, 115 : 333 - 334
  • [47] COVID-19: An Update on Epidemiology, Prevention and Treatment, September-2023
    Simsek-Yavuz, Serap
    INFECTIOUS DISEASES AND CLINICAL MICROBIOLOGY, 2023, 5 (03): : 165 - 187
  • [48] Comment on Williamson et al. (OpenSAFELY): The Table 2 Fallacy in a Study of COVID-19 Mortality Risk Factors
    Westreich, Daniel
    Edwards, Jessie K.
    van Smeden, Maarten
    EPIDEMIOLOGY, 2021, 32 (01) : E1 - E2
  • [49] Comment on case series of COVID-19 in patients with myasthenia gravis: a single institution experience by Županić et al.
    Giuliana Galassi
    Alessandro Marchioni
    Acta Neurologica Belgica, 2022, 122 : 559 - 560
  • [50] Authors' reply to: Rivera-Lillo et al. comment on: Early rehabilitation in post-acute COVID-19 patients: data from an Italian COVID-19 rehabilitation unit and proposal of a treatment protocol
    Curci, Claudio
    Pisano, Fabrizio
    Negrini, Francesco
    de Sire, Alessandro
    EUROPEAN JOURNAL OF PHYSICAL AND REHABILITATION MEDICINE, 2021, 57 (01) : 172 - 173
12345